| International Conference on Nano Bio Intelligence |
|
 | Prof. Justin Gooding, University of New South Wales |
| Scientia Professor Justin Gooding is currently an NHMRC Leadership Fellow and a co-director of the Australian Centre for NanoMedicine. He is a Fellow of the Australian Academy of Science (FAA), the Australian Academy of Technology and Engineering, the Australian Academy of Health and Medical Sciences and the International Society of Electrochemistry. He is the inaugural Editor-in-Chief of the journal ACS Sensors. |
|
 | Prof. Martina Stenzel, University of New South Wales |
| Martina Stenzel is a Scientia Professor in the School of Chemistry, UNSW, a Fellow of the Australian Academy of Science (FAA) and an ARC Laureate Fellow. Her research interest is focused on the synthesis of functional nanoparticles for drug delivery applications. Martina Stenzel published more than 350 peer reviewed papers mainly on polymer and nanoparticle design. |
|
 | Prof. Jie Lu, University of Technology, Sydney |
| Distinguished Professor Jie Lu, AO (Officer of the Order of Australia), FIEEE, FIFSA, FACS, Australian Laureate Fellow is an internationally renowned scientist in the area of computational intelligence, who has made fundamental and influential contributions, particularly in fuzzy transfer learning, concept drift, data-driven decision support systems, and recommender systems. Her research has huge positive implications and significant impact on her research community and for society and economics. |
|
 | Prof. Hongxia Wang, Queensland University of Technology |
| Professor Hongxia Wang, Georgina Sweet Australian Laureate Fellow is a leading researcher in advanced solar cells and energy storage technologies. In the past 20 years, her research has been focused on development of cost-effective optoelectrical devices (solar cells, light emitting diodes, photodetectors), supercapacitors, batteries, solar fuels as well as related integrated devices for variable environmental conditions both on earth and in outer space through innovative materials design and synthesis, device architecture design as well as in-depth understanding of the fundamental mechanism of the materials in devices. |
|
 | Prof. Jennifer Gamble, University of Sydney |
| Professor Jennifer Gamble is an internationally recognised research leader in the field of endothelial cell function and holds the Inaugural Wenkart Chair of the Endothelium. Her interests lie in understanding the function of blood vessels, particularly the endothelial cells that form the barrier between the blood and the tissues. Her initial work on the action of TNF on the endothelium to support neutrophil adhesion redefined and forms the basis for our understanding of the central role of the endothelium in inflammation. |
|
 | Prof. Kourosh Kalantar Zadeh, University of Sydney |
| Professor Kourosh Kalantar Zadeh a Professor at the University of Sydney who has the responsibility of Advising on High Impact Initiatives at the Faculty of Engineering. He is also one of the Australian Research Council (ARC) Laureate Fellows of 2018. Prof. Kalantar-Zadeh is involved in research in the fields of chemical engineering, materials sciences, electronics, and medical devices. He has co-authored >500 scientific papers and books and is also a member of the editorial boards of journals including ACS Sensors, Advanced Materials Technologies, Nanoscale and ACS Nano. He is also an Associate Editor for ACS Applied Nano Materials journal. |
|
 | Prof. Hang Ta, Griffith University |
| Professor Hang Ta is a Heart Foundation Future Leader Fellow and currently leads a team of 12 students and 2 postdocs working on nanomaterials for diagnosis and treatment of life-threatening diseases such as inflammatory and cardiovascular disease, cancerous diseases and blood disorder diseases. Her research addresses solutions for current problems in diagnosis and treatment of diseases. She is a pioneering bio-nanomaterials researcher developing innovative nanomaterials and magnetic resonance imaging (MRI) nanosensors for molecular imaging and drug delivery for cardiovascular disease. |
|
 | Prof. Krasimir Vasilev, Flinders University |
| Professor Krasimir Vasilev is currently a Matthew Flinders Professor and a Professor in Biomedical Nanotechnology, and a NHMRC Leadership Fellow. He has been awarded research funding in excess of 25 million dollars and published more than 320 research papers, reviews and book chapters. His research also results in translation of research discoveries to tangible commercial outcomes. Between 2017 and 2020, a bladder cancer diagnostic technology developed in Prof. Vasilev’s laboratory was translated to the manufacturing facility of the industrial partner (Motherson Innovations Pty Ltd). This commercial development is supported by a 5 million dollar (cash) CRC-P project fundend from the industrial partner and the federal government. In another large (6 million dollars) project, he is working with an Australian implant manufacturer on translating a breakthrough antibacterial technology to hip, knee and dental implants. |
|
 | Prof. Yuling Wang, Macquarie University |
| Professor Yuling Wang completed her PhD degree at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences in 2009. After graduation, she took up a postdoctoral position at Purdue University, working in the Bindely Bioscience Center on the project of Nanobiotechnology. After working at Purdue University for 22 months, she was awarded a prestigious Alexander von Humboldt fellowship (AvH) and worked at the University of Osnabrücker in Germany for 2 years. Following her AvH fellowship, she got an individual grant supported by the German Research Foundation (DFG), working in the University of Duisburg-Essen on the topic of multiplexed cytokines detection with plasmonic nanostructures before commencing her ARC DECRA fellowship in 2014. Towards the end of her ARC DECRA Fellow, she was appointed as a Senior Lecturer at Macquarie University in 2017 and was promoted to Associate Professor in 2020 and then Professor in 2023. She is also a Chief Investigator within ARC Center of Excellence for Nanoscale BioPhotonics (CNBP) and leads the SERS program for in vitro diagnostics. |
|
 | Prof. Megan Lord, University of New South Wales |
| Megan Lord is a Professor and Australian Research Council (ARC) Future Fellow in the Graduate School of Biomedical Engineering and Associate Dean Research for the Faculty of Engineering, UNSW Sydney. Megan is recognised as a leader in the field of biomaterials (including nanomedicines and nanoparticles) and specifically the engineering of cell-biomaterial interactions for applications in drug delivery and tissue repair. Her research in underpinned by expertise in the analysis of cell-biomaterial interactions, matrix biology, and the biophysics of molecular interactions. She collaborates internationally across academia and industry. Professor Lord's research has been published in over 100 peer-reviewed publications and has been supported by multiple national grants including an ARC Australian Postdoctoral Fellowship (2010-2012) and an ARC Future Fellowship (2022-2026). Megan has mentored emerging academic and engineering leaders having supervised 22 PhD/MPhil and 140 Engineering Honours candidates to completion. |
|
 | Prof. Wenlong Cheng, University of Sydney |
| Wenlong Cheng is a professor the School of Biomedical Engineering at The University of Sydney, Australia. He is currently NHMRC Investigator Leadership Fellow and a fellow of Royal Society of Chemistry and was an Ambassador Tech Fellow in Melbourne Centre for Nanofabrication. He founded Monash NanoBionics lab at the Monash University in 2010. His research interest lies at the Nano-Bio Interface, particularly self-assembly of 2D plasmonic nanomaterials, DNA nanotechnology, electronic skins and stretchable energy devices. He has published >200 papers. He is currently the scientific editor for Nanoscale Horizon (Royal Society of Chemistry) and the editorial board members for a few journals including Nanoscale, Nanoscale Horizons, Nanoscale Advances, Advanced Sensor Research, Advanced Electronic Materials, ChemNanomat, Advanced Sensors and Energy Materials,iScience, Chemosensors, FlexTech, Wearable Electronics, and Austin Journal of Biomedical Engineering. |
|
 | A/Prof. Kang Liang, University of New South Wales |
| Dr Kang Liang FRSC is a Scientia Associate Professor and group leader of Nano-Micro-Bio Systems. He received his Bachelor (Hon) and PhD degrees from the School of Chemical and Biomolecular Engineering at The University of Melbourne in 2010 and 2014, respectively. After conferral of his PhD, he joined CSIRO Manufacturing under the Office-of-the-Chief-Executive scheme in 2014 as a research fellow and then became a research scientist. In 2017, he joined the School of Chemical Engineering and the Graduate School of Biomedical Engineering at UNSW Sydney. He is a Co-Chair of Australian Synchrotron Program Advisory Committee for SAXS/WAXS and BioSAXS. He is a Fellow of the Royal Society of Chemistry. He is an awardee of Victoria Fellowship in Physical Sciences in 2017. He is a former NHMRC Career Development Fellow (2019-2022), and an ARC Future Fellow (2023-2027). |
|
 | Prof. Benjamin Thierry, University of South Australia |
| Prof Benjamin Thierry is the University of South Australia Professor of Bioengineering and a Research Leader at the Future Industries Institute. He is a NHMRC Leadership Fellow. He received his PhD in Biomedical Engineering from McGill University in 2004 and has since received prestigious awards, including two NHMRC Career Development Fellowships. Prof Thierry leads the translational Bioengineering group which aims to develop and implement novel biodiagnostic and prognostic technologies and is currently involved in several clinical translation/commercialization activities. A significant outcome of his research has been the establishment of precision cancer treatment company Ferronova Pty Ltd, Ferronova has raised over $12 million to fund several on-going clinical trials in Australia and the US. With the support of a NHMRC Development and CRC-P grants and in collaboration with Ferronova and UK-based company Diagnostic Green, Prof Thierry is currently leading a program of research aimed at developing molecular agent for image guided cancer surgery and radiotherapy. |
|
 | Prof. David Ziegler, Children's Cancer Institute & UNSW |
| Professor David Ziegler is Group Leader of the Brain Tumours Group at Children's Cancer Institute, and Chair of Clinical Trials for the Zero Childhood Cancer Program, co-led by Children's Cancer Institute and Sydney Children's Hospital Randwick (SCH). He also holds a conjoint appointment with UNSW in the Faculty of Medicine. He is head of the neuro-oncology program at Sydney Children’s Hospital, and runs the clinical trials program at the Kids Cancer Centre. An important focus of David’s work is developing new clinical trials that bring research discoveries into the clinic to treat children with the most aggressive cancers. He has developed and led several innovative national and international trials for children with brain tumours, leukaemia, and solid tumours. He is the clinical lead of trials run through the Zero Childhood Cancer Program and leads the early phase clinical trials program at the Kids Cancer Centre. |
|
 | Prof. Arnold Lining Ju, University of Sydney |
| Prof. Ju currently holds an Heart Foundation Future Leader Fellowship, working at the interface between mechanical engineering and mechanobiology. His team has pioneered multiple biomechanical nanotools, including blood clot-on-chip microfluidic devices (Nature Materials 2019), single-cell biomembrane force probes (Nature Communications 2018), and 4-D haemodynamic modelling (Nature 2021). Recently, he was awarded the prestigious mid-career Snow Fellowship. His vision is to build novel platforms that integrate advanced biomanufacturing, high-throughput biomechanical manipulation, and artificial intelligence for biobank data processing. His track record spans developing, characterising, and evaluating innovations of 3D organoids and organ-on-chips, mechanobiology, imaging probes and biosensors, bio-nanotechnology, and image-based deep learning. These large facilities should provide significant benefits to interdisciplinary research in biofabrication, biomechanics and point-of-care microtechnologies. |
|
| Join the Editors |
| Wiley: |
| Dr. Guangchen Xu (Director, Physical Sciences APAC, Wiley) |
| Dr. Duoduo Liang (Deputy Editor, Advanced Materials; Senior Manager, Wiley) |
| Dr. Xiaoyu Zhang (Deputy Editor, Advanced Science; Manager, Wiley) |
| Dr. Yanze Wei (Deputy Editor, Angewandte Chemie) |
|